ARYX THERAPEUTICS Stock Probability of Future Stock Price Finishing Over 5.0E-4

ARYX
 Stock
  

USD 0.0005  0.00  0.00%   

ARYX THERAPEUTICS's future price is the expected price of ARYX THERAPEUTICS instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of ARYX THERAPEUTICS INC performance during a given time horizon utilizing its historical volatility.
  
Please continue to ARYX THERAPEUTICS Backtesting, ARYX THERAPEUTICS Valuation, ARYX THERAPEUTICS Correlation, ARYX THERAPEUTICS Hype Analysis, ARYX THERAPEUTICS Volatility, ARYX THERAPEUTICS History as well as ARYX THERAPEUTICS Performance. Please specify ARYX THERAPEUTICS time horizon, a valid symbol (red box) and a target price (blue box) you would like ARYX THERAPEUTICS odds to be computed.

ARYX THERAPEUTICS Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ARYX THERAPEUTICS for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ARYX THERAPEUTICS INC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
ARYX THERAPEUTICS generated a negative expected return over the last 90 days
ARYX THERAPEUTICS has some characteristics of a very speculative penny stock
ARYX THERAPEUTICS has a very high chance of going through financial distress in the upcoming years
The company currently holds 11.57 M in liabilities. ARYX THERAPEUTICS INC has a current ratio of 0.46, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist ARYX THERAPEUTICS until it has trouble settling it off, either with new capital or with free cash flow. So, ARYX THERAPEUTICS's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like ARYX THERAPEUTICS INC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for ARYX THERAPEUTICS to invest in growth at high rates of return. When we think about ARYX THERAPEUTICS's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 19.72 M. Net Loss for the year was (18.33 M) with profit before overhead, payroll, taxes, and interest of 0.
ARYX THERAPEUTICS INC currently holds about 2.95 M in cash with (20.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

ARYX THERAPEUTICS Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ARYX THERAPEUTICS Stock often depends not only on the future outlook of the current and potential ARYX THERAPEUTICS's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ARYX THERAPEUTICS's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out0.27%
Shares Short Prior Month95.84k
Date Short Interest28th of February 2011

ARYX THERAPEUTICS Technical Analysis

ARYX THERAPEUTICS's future price can be derived by breaking down and analyzing its technical indicators over time. ARYX THERAPEUTICS Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of ARYX THERAPEUTICS INC. In general, you should focus on analyzing ARYX THERAPEUTICS Stock price patterns and their correlations with different microeconomic environments and drivers.

ARYX THERAPEUTICS Predictive Forecast Models

ARYX THERAPEUTICS time-series forecasting models is one of many ARYX THERAPEUTICS's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ARYX THERAPEUTICS's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about ARYX THERAPEUTICS INC

Checking the ongoing alerts about ARYX THERAPEUTICS for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for ARYX THERAPEUTICS INC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
ARYX THERAPEUTICS generated a negative expected return over the last 90 days
ARYX THERAPEUTICS has some characteristics of a very speculative penny stock
ARYX THERAPEUTICS has a very high chance of going through financial distress in the upcoming years
The company currently holds 11.57 M in liabilities. ARYX THERAPEUTICS INC has a current ratio of 0.46, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist ARYX THERAPEUTICS until it has trouble settling it off, either with new capital or with free cash flow. So, ARYX THERAPEUTICS's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like ARYX THERAPEUTICS INC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for ARYX THERAPEUTICS to invest in growth at high rates of return. When we think about ARYX THERAPEUTICS's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 19.72 M. Net Loss for the year was (18.33 M) with profit before overhead, payroll, taxes, and interest of 0.
ARYX THERAPEUTICS INC currently holds about 2.95 M in cash with (20.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Please continue to ARYX THERAPEUTICS Backtesting, ARYX THERAPEUTICS Valuation, ARYX THERAPEUTICS Correlation, ARYX THERAPEUTICS Hype Analysis, ARYX THERAPEUTICS Volatility, ARYX THERAPEUTICS History as well as ARYX THERAPEUTICS Performance. You can also try Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for analysis

When running ARYX THERAPEUTICS INC price analysis, check to measure ARYX THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ARYX THERAPEUTICS is operating at the current time. Most of ARYX THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of ARYX THERAPEUTICS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ARYX THERAPEUTICS's price. Additionally, you may evaluate how the addition of ARYX THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Is ARYX THERAPEUTICS's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ARYX THERAPEUTICS. If investors know ARYX THERAPEUTICS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ARYX THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
237.6 K
Return On Assets
(0.75) 
The market value of ARYX THERAPEUTICS INC is measured differently than its book value, which is the value of ARYX THERAPEUTICS that is recorded on the company's balance sheet. Investors also form their own opinion of ARYX THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is ARYX THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ARYX THERAPEUTICS's market value can be influenced by many factors that don't directly affect ARYX THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ARYX THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine ARYX THERAPEUTICS value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ARYX THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.